Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-22

Clinical Trial Update: Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting persistence of Hepatitis B antibodies and immune response after a Hepatitis B vaccine challenge in children previously vaccinated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2012-08-22